Skip to main content
. 2014 Feb 14;9(2):e88967. doi: 10.1371/journal.pone.0088967

Figure 3. Live CTC counts as an independent indicator of disease progression.

Figure 3

CTC counts detected from mCRPC patients were analyzed along with the progress of therapeutic intervention. Two representative results are shown. A, the progressive increment of CTC counts in patient 41 correlated with clinical metastatic progression. B, the persistent low CTC counts in patient 42 correlated with beneficial anticancer therapies.